Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 141.60 is 77% above its 3-year average of 80.10, near the high end of its 3-year range (39.37–167.52).
As of 2026-10-06T14:16:36.818Z. 7.31% below its 12-month average of 152.77.
Calculation as of: 2026-10-06T14:16:36.818Z.
Quote observation: 2026-10-06T14:15:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 964f8bcea024e80fb52d816f3b4380b7088b93770ce31cf7c1083d390364c537
PE Ratio (141.60) = Close Price ($54.46) / Diluted TTM EPS ($0.38)
PE RATIO
141.60
PE RATIO AVG TTM
152.77
PE RATIO AVG 3Y
80.10
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.31%
CURRENT VS 3Y AVG
+76.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.67
median of 149 covered companies
CURRENT VS SECTOR MEDIAN
+451.62%
vs the sector median at left
Eton Pharmaceuticals, Inc.
Market Cap
$1.49B
PE Ratio
141.60
TTM Avg
152.77
3Y Avg
80.10
5Y Avg
N/A
Market Cap
$1.46B
PE Ratio
12.43
TTM Avg
30.95
3Y Avg
30.73
5Y Avg
31.04
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | $1.49B | 141.60 | 152.77 | 80.10 | N/A |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.52B | N/A | 174.30 | 183.89 | 183.89 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 12.43 | 30.95 | 30.73 | 31.04 |
| Innoviva, Inc. (INVA)vs › | $1.53B | 5.07 | 13.44 | 25.81 | 17.64 |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 8.93 | 9.41 | 9.41 | 62.32 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.40B | N/A | 0.13 | 0.13 | 0.13 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.64B | N/A | N/A | N/A | N/A |
At 141.6, P/E is above its 3-year median — higher than 81% of readings in its 3-year history.
3-year low
39.4
median
86.5
3-year high
167.5
Trailing P/E
141.6
Forward P/E
50.1
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$54.46
Forward EPS (Est.)
$1.09
Forward P/E
50.08
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 144.62 |
| 2026-10-02 | 143.94 |
| 2026-10-01 | 135.15 |
| 2026-09-30 | 133.88 |
| 2026-09-29 | 153.90 |
| 2026-09-28 | 153.87 |
| 2026-09-25 | 149.97 |
| 2026-09-24 | 154.68 |
| 2026-09-23 | 144.59 |
| 2026-09-22 | 148.44 |
| 2026-09-21 | 143.81 |
| 2026-09-18 | 144.31 |
| 2026-09-17 | 148.39 |
| 2026-09-16 | 146.52 |
| 2026-09-15 | 142.82 |
| 2026-09-14 | 149.82 |
| 2026-09-11 | 148.41 |
| 2026-09-10 | 150.49 |
| 2026-09-09 | 152.96 |
| 2026-09-08 | 154.32 |
| 2026-09-04 | 151.98 |
| 2026-09-03 | 155.75 |
| 2026-09-02 | 161.10 |
| 2026-09-01 | 157.12 |
| 2026-08-31 | 157.15 |
| 2026-08-28 | 155.43 |
| 2026-08-27 | 162.95 |
| 2026-08-26 | 162.82 |
| 2026-08-25 | 163.94 |
| 2026-08-24 | 167.52 |
| 2026-08-21 | 165.03 |
| 2026-08-20 | 155.77 |
| 2026-08-19 | 159.85 |
| 2026-08-18 | 164.92 |
| 2026-08-17 | 160.50 |
| 2026-08-14 | 153.04 |
| 2024-08-08 | 94.27 |
| 2024-08-07 | 90.89 |
| 2024-08-06 | 91.15 |
| 2024-08-05 | 91.67 |
| 2024-08-02 | 93.23 |
| 2024-08-01 | 94.53 |
| 2024-07-31 | 93.75 |
| 2024-07-30 | 92.19 |
| 2024-07-29 | 92.19 |
| 2024-07-26 | 93.23 |
| 2024-07-25 | 92.97 |
| 2024-07-24 | 92.45 |
| 2024-07-23 | 92.45 |
| 2024-07-22 | 91.41 |
| 2024-07-19 | 91.15 |
| 2024-07-18 | 89.06 |
| 2024-07-17 | 93.49 |
| 2024-07-16 | 93.49 |
| 2024-07-15 | 86.98 |
| 2024-07-12 | 88.80 |
| 2024-07-11 | 89.32 |
| 2024-07-10 | 87.24 |
| 2024-07-09 | 89.32 |
| 2024-07-08 | 88.54 |
| 2024-07-05 | 86.46 |
| 2024-07-03 | 85.68 |
| 2024-07-02 | 85.42 |
| 2024-07-01 | 88.54 |
| 2024-06-28 | 85.68 |
| 2024-06-27 | 86.46 |
| 2024-06-26 | 87.50 |
| 2024-06-25 | 85.42 |
| 2024-06-24 | 86.46 |
| 2024-06-21 | 86.98 |
| 2024-06-20 | 85.94 |
| 2024-06-18 | 84.90 |
| 2024-06-17 | 87.24 |
| 2024-06-14 | 92.71 |
| 2024-06-13 | 94.53 |
| 2024-06-12 | 94.53 |
| 2024-06-11 | 94.27 |
| 2024-06-10 | 93.75 |
| 2024-06-07 | 94.01 |
| 2024-06-06 | 94.79 |
| 2024-06-05 | 94.79 |
| 2024-06-04 | 93.75 |
| 2024-06-03 | 94.53 |
| 2024-05-31 | 92.45 |
| 2024-05-30 | 94.27 |
| 2024-05-29 | 96.35 |
| 2024-05-28 | 93.75 |
| 2024-05-24 | 93.23 |
| 2024-05-23 | 93.75 |
| 2024-05-22 | 95.31 |
| 2024-05-21 | 93.49 |
| 2024-05-20 | 94.79 |
| 2024-05-17 | 94.27 |
| 2024-05-16 | 95.05 |
| 2024-05-15 | 95.05 |
| 2024-05-14 | 94.53 |
| 2024-05-13 | 92.45 |
| 2024-05-10 | 89.32 |
| 2024-03-14 | 50.97 |
| 2024-03-13 | 51.20 |
| 2024-03-12 | 50.29 |
| 2024-03-11 | 52.11 |
| 2024-03-08 | 51.43 |
| 2024-03-07 | 51.31 |
| 2024-03-06 | 49.49 |
| 2024-03-05 | 50.06 |
| 2024-03-04 | 51.09 |
| 2024-03-01 | 50.97 |
| 2024-02-29 | 50.86 |
| 2024-02-28 | 51.20 |
| 2024-02-27 | 51.31 |
| 2024-02-26 | 51.09 |
| 2024-02-23 | 51.09 |
| 2024-02-22 | 51.09 |
| 2024-02-21 | 50.86 |
| 2024-02-20 | 49.83 |
| 2024-02-16 | 50.29 |
| 2024-02-15 | 52.46 |
| 2024-02-14 | 50.17 |
| 2024-02-13 | 50.51 |
| 2024-02-12 | 50.40 |
| 2024-02-09 | 50.40 |
| 2024-02-08 | 50.40 |
| 2024-02-07 | 52.34 |
| 2024-02-06 | 53.94 |
| 2024-02-05 | 52.34 |
| 2024-02-02 | 51.31 |
| 2024-02-01 | 52.57 |
| 2024-01-31 | 53.37 |
| 2024-01-30 | 54.17 |
| 2024-01-29 | 53.83 |
| 2024-01-26 | 52.11 |
| 2024-01-25 | 50.74 |
| 2024-01-24 | 50.86 |
| 2024-01-23 | 51.09 |
| 2024-01-22 | 50.17 |
| 2024-01-19 | 47.31 |
| 2024-01-18 | 46.63 |
| 2024-01-17 | 47.31 |
| 2024-01-16 | 46.74 |
| 2024-01-12 | 49.94 |
| 2024-01-11 | 54.17 |
| 2024-01-10 | 55.54 |
| 2024-01-09 | 56.34 |
| 2024-01-08 | 57.49 |
| 2024-01-05 | 49.60 |
| 2024-01-04 | 53.03 |
| 2024-01-03 | 52.91 |
| 2024-01-02 | 52.46 |
| 2023-12-29 | 50.06 |
| 2023-12-28 | 52.57 |
| 2023-12-27 | 53.14 |
| 2023-12-26 | 53.26 |
| 2023-12-22 | 52.46 |
| 2023-12-21 | 51.77 |
| 2023-12-20 | 51.89 |
| 2023-12-19 | 52.23 |
| 2023-12-18 | 51.89 |
| 2023-12-15 | 50.86 |
| 2023-12-14 | 49.37 |
| 2023-12-13 | 49.37 |
| 2023-12-12 | 45.37 |
| 2023-12-11 | 44.91 |
| 2023-12-08 | 41.14 |
| 2023-12-07 | 41.49 |
| 2023-12-06 | 40.69 |
| 2023-12-05 | 41.26 |
| 2023-12-04 | 41.83 |
| 2023-12-01 | 42.29 |
| 2023-11-30 | 40.46 |
| 2023-11-29 | 41.94 |
| 2023-11-28 | 42.63 |
| 2023-11-27 | 42.86 |
| 2023-11-24 | 42.86 |
| 2023-11-22 | 41.60 |
| 2023-11-21 | 40.57 |
| 2023-11-20 | 39.37 |
| 2023-11-17 | 40.46 |
| 2023-11-16 | 40.34 |
| 2023-11-15 | 42.17 |
| 2023-11-14 | 42.40 |
| 2023-11-13 | 40.91 |
| 2023-11-10 | 43.89 |